QMENTA 2025 Year in Review: Clinical Imaging Infrastructure Milestones

Multi-center imaging studies face a persistent infrastructure challenge. Coordinating data from multiple institutions requires standardizing diverse imaging protocols, managing terabytes of data, ensuring quality control across sites, and maintaining regulatory compliance throughout. These technical and operational barriers slow clinical research and delay the translation of imaging innovations into clinical practice.

The complexity multiplies when studies span years and involve dozens of sites. Research teams spend more time managing infrastructure than analyzing results. Pharmaceutical sponsors struggle with data quality and timeline predictability. Academic institutions lack the resources to build and maintain enterprise-grade imaging platforms independently.

This infrastructure gap has real consequences. Promising imaging biomarkers remain trapped in single-institution studies. Multi-center validation takes years longer than necessary. Clinical translation stalls not because of scientific limitations, but because of operational ones.

Platform Capabilities That Matured in 2025

At QMENTA, several platform capabilities reached operational maturity this past year. Enterprise readiness became foundational. Single Sign-On integration, automated audit trail generation, and enhanced two-factor authentication now meet the security and compliance requirements of large pharmaceutical companies and academic medical centers. These capabilities are not features but prerequisites for institutional adoption.

The platform maintained 99.977% uptime with zero security incidents throughout the year. This level of operational reliability enables multi-year studies where imaging infrastructure must function as a utility, not a project-specific tool.

Regulatory validation advanced through external audits from pharmaceutical partners, completed with zero nonconformities. These audits validated quality management systems aligned with IEC 62304 for software development and ISO 31000 for risk management.

Technical capabilities expanded to support emerging clinical needs. Integration of advanced imaging modalities including 7-Tesla systems positions the platform for ultra-high-field imaging studies, an emerging high-value market segment.

TotalSegmentator is a widely adopted open-source AI model (1,500+ citations) that segments 104 anatomical structures from CT scans across the entire body. Its integration gives QMENTA instant multi-organ capabilities across AI device companies, academic core labs, and automated QC for CROs in body imaging trials.

A complete imaging review workflow for clinical trials launched this year, addressing the operational requirements of an important group of customers. The system supports end-to-end data management from upload through central review, with compliance features including comprehensive audit trails and high-speed viewing capabilities.

Clinical Translation and Sustained Partnerships

The infrastructure approach proved effective in supporting consequential clinical research. A multi-center MS diagnostic imaging study that began as a modest pilot in 2018 expanded to connect 10 top-tier academic institutions. The platform served as the operational backbone for research that contributed to revising the McDonald Criteria for multiple sclerosis in 2025, directly influencing how MS is diagnosed in clinical practice worldwide.

This validation of the infrastructure model created network effects. A major biomedical imaging research institute engaged the platform initially for a pancreas imaging project requiring the upload and processing of 70,000 CT volumes in two weeks. The operational velocity demonstrated, which typically requires months with conventional approaches, led to expansion into cardiac MRI within four months.

Sustained institutional partnerships characterized the year. Partner institutions remained engaged throughout multi-year study periods. Approximately half provided formal testimonials documenting platform utility. Twenty percent generated direct referrals to peer institutions, indicating that operational reliability and scientific value translate into institutional recommendations.

The shift from project-based deployments to infrastructure partnerships reflects platform maturity. Institutions increasingly view the platform not as a vendor service but as an embedded research infrastructure.

Building on Operational Foundations

The platform capabilities and institutional partnerships established in 2025 create a foundation for continued clinical translation. As we look forward, imaging diagnostics represents a natural extension of the infrastructure model, applying the same data management, quality control, and workflow capabilities developed for clinical trials to diagnostic applications.

QMENTA continues to focus on enabling multi-center imaging research and supporting the translation of imaging innovations into clinical practice. The operational infrastructure required for these applications becomes more critical as imaging studies scale and as regulatory requirements for imaging data increase.

The work continues.